HYBRID EVENT: You can participate in person at Boston, Massachusetts, USA or Virtually from your home or work.

7th Edition of Global Conference on

Addiction Medicine, Behavioral Health and Psychiatry

October 19-21, 2026 | Boston, Massachusetts, USA

Cross-Tolerance in Substance Use

Cross-Tolerance in Substance Use

Cross-tolerance occurs when the use of one substance reduces sensitivity to another, often due to overlapping mechanisms of action. For example, tolerance to alcohol may result in reduced responsiveness to benzodiazepines, as both affect the GABAergic system. This phenomenon complicates treatment and increases the risk of overdose when individuals switch or combine substances to achieve the desired effect. Cross-tolerance is a significant challenge in managing polysubstance use disorders, as it may necessitate higher doses of medications for effective treatment, increasing potential side effects. Treatment strategies include careful assessment of cross-tolerance patterns, gradual tapering protocols, and alternative medications that bypass tolerance mechanisms. Recognizing cross-tolerance is critical in designing safer and more effective addiction management plans.

Committee Members
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2026 - Nile Stanley

Nile Stanley

University of North Florida, United States
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2026 - Ann Marie Leonard Zabel

Ann Marie Leonard Zabel

Curry College, United States
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2026 - Edie Raether

Edie Raether

NeuroShifts and Wings for Wishes Academy, United States
GAB 2026 Speakers
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2026 - Sindu Padmanabhan

Sindu Padmanabhan

Bharathiar University, India
Tags

Submit your abstract Today

Watsapp